OncologyTube Professional - Patients Click Here
323,693 video views
kidneycancer: Videos
10:51
Alison Fielding, MD, presents A Patient View at the International Kidney Cancer Symposium 2018
by:kidneycancer | 294 views
13:46
Lisa M Pickering, MD, presents Centralisation of RCC Management: What is the volume needed to improve? The Oncologist’s View: Is there an argument for centralisation? at the International Kidney Cancer Symposium 2018
by:kidneycancer | 254 views
12:31
Mr. Rajesh Nair FRCS (Urol.), FEBU, MSc., presents Centralisation of Renal Cell Carcinoma Management: What is the Volume Needed to Improve? The Surgeon’s Point of View at the International Kidney Cancer Symposium 2018
by:kidneycancer | 259 views
09:55
Guillermo de Velasco MD, PhD, presents Treatment after Immune checkpoint inhibition: Impact on biology? at the International Kidney Cancer Symposium 2018.
by:kidneycancer | 259 views
15:21
Laurence Albiges, MD, PhD, presents Treatment after immune checkpoint in first/second line setting: Clinical perspective at the International Kidney Cancer Symposium 2018
by:kidneycancer | 309 views
10:54
Ravi Barod PhD FRCS (Urol) presents Minimally invasive partial nephrectomy is NOT a cause of seeding of RCC at the International Kidney Cancer Symposium.
by:kidneycancer | 161 views
62:59
Christopher G. Wood, M.D., F.A.C.S. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX chairs an esteem panel to discuss challenging renal cases at the International Kidney Cancer symposium 2018. Viktor Grunwald, Camillo Porta, Seva Matveev, Karim Bensalah
by:kidneycancer | 76 views
15:39
Paul Russo, MD, FACS, presents DEBATE: Cancer Seeding and Minimally Invasive Kidney Tumor Surgery at the International Kidney Cancer Symposium 2018
by:kidneycancer | 69 views
17:10
Sumanta Kumar Pal, M.D. Associate Professor, Department of Medical Oncology & Therapeutics Research Co-Director, Kidney Cancer Program City of Hope Comprehensive Cancer Center discusses the New Generation of Biomarkers for IO: Fact or Fiction? at the 13th European International Kidney Cancer Symposium 2018 in Prague.
by:kidneycancer | 175 views
10:55
Bernard Escudier, Gustave Roussy, Villejuif, France asks teh question "Combination Trials with New IO Agents: How Can we Define the Best Treatment with Current Data?" at the 13th European International Kidney Cancer Symposium 2018 in Prague.
by:kidneycancer | 64 views
dsfsd